Advertisement
Singapore markets close in 7 hours 44 minutes
  • Straits Times Index

    3,283.99
    -3.76 (-0.11%)
     
  • Nikkei

    37,617.53
    -10.95 (-0.03%)
     
  • Hang Seng

    17,284.54
    0.00 (0.00%)
     
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • Bitcoin USD

    63,986.70
    -533.08 (-0.83%)
     
  • CMC Crypto 200

    1,388.79
    +6.22 (+0.45%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,339.40
    -3.10 (-0.13%)
     
  • Crude Oil

    83.88
    +0.31 (+0.37%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,568.08
    -1.17 (-0.07%)
     
  • Jakarta Composite Index

    7,155.29
    -7,174.53 (-50.07%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Is Invitae in Danger of Running Out of Money?

Is Invitae in Danger of Running Out of Money?

Invitae (NYSE: NVTA) is a genetic testing company that's in its early growth stages, so shareholders should expect to take on some risk with a stock like this. Or could it be a good long-term investment for growth investors to buy and hold? A big problem with Invitae is that it is burning through lots of cash.